The pharmaceutical industry is moving towards nanoparticles as vehicles for drug delivery in various forms. Therefore, separation, size characterization and purification of biological nanoparticles will be a fundamental necessity in the near future. Conventional chromatography techniques that use a stationary phase have serious limitations that will prevent them from serving this industry efficiently. In addition, often the use of such instruments require expert personnel for operating and trouble shooting purposes. Imessa Research is developing an instrument that will separate and characterize bio nanoparticles based on their interaction with a physical force rather than a stationary phase. The instrument will cover a broad range of a few nanometers to hundreds of nanometers. A user-friendly software, turn-key design, and an innovative customer support model will ensure facile use of the instrument by the industry and non-expert users.
CEO
Stay connected to everything happening at Altitude Lab.
You can trust us with your email. We don't spam.